Naked DNA and adenoviral immunizations for immunotherapy of prostate cancer: A phase I/II clinical trial

European Urology

Volumn 38, Issue 2, 2000, Pages 208-217

  Mincheff, Milcho ^a,c,e   Tchakarov, Stoyan ^b   Zoubak, Serguei ^a   Loukinov, Dmitri ^a   Botev, Chavdar ^c   Altankova, Iskra ^d   Georgiev, Georgi ^d   Petrov, Stefan ^b   Meryman, Harold T ^a  

^a American Foundation for Biological Research   (United States)

^b St Ann Hospital   (Bulgaria)

^c National Center of Hematology and Transfusion Medicine   (Bulgaria)

^d UNIVERSITY HOSPITAL ST IVAN RILSKI   (Bulgaria)

^e BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

CD86; DNA immunization; Expression vector; Granulocyte macrophage colony stimulating factor; Immunotherapy; Naked DNA; Plasmid; Prostate specific antigen; Prostate specific membrane antigen; Recombinant adenovirus

Indexed keywords

DNA; PROSTATE SPECIFIC MEMBRANE ANTIGEN;

ADENOVIRUS; ADULT; ARTICLE; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; EXPRESSION VECTOR; HUMAN; IMMUNIZATION; MALE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PLASMID; PRIORITY JOURNAL; PROSTATE CANCER; VIRUS RECOMBINANT;

EID: 0033948976     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020281     Document Type: Article

References (72)